Annual Report on the Implementation of the Corruption Risk Prevention Plan
Bluepharma Indústria Farmacêutica, S.A. has approved the Annual Report on the Implementation of the Corruption Risk Prevention and Related Offences Plan for the year 2025.
This report has been prepared in compliance with the General Regime for the Prevention of Corruption (RGPC), established by Decree-Law No. 109-E/2021. Under this legal framework, entities within its scope are required to carry out periodic assessments of their Corruption Risk Prevention Plans, with the purpose of monitoring the effectiveness of the preventive measures implemented and evaluating the extent to which identified risks have been mitigated.
The completion of this annual assessment is not only a legal requirement but also an opportunity to reinforce and continuously improve Bluepharma’s internal practices. It allows for the identification of potential weaknesses, the strengthening of existing control mechanisms, and the consolidation of an organisational culture grounded in ethics, transparency, and integrity — values that Bluepharma recognises as fundamental to its activity.
All employees play an active role in promoting an organisation guided by integrity and transparency. Compliance with the principles and rules established in the Plan is a shared responsibility, regardless of role or function.
The document is available for consultation here.